The majority distinguished the case from TransUnion LLC v
Roche, AstraZeneca, Viking Therapeutics, and Structure Therapeutics all have promising oral or next-generation programs in development
13,15 Treatment effects were applied in each model cycle and maintained while patients were on treatment
Theres no one-size-fits-all answer
What barriers might interfere with an accurate pain assessment (e.g., recall bias, communication challenges, incomplete records), and how can clinicians address them in practice
However, a large multicenter cohort study identified endometriosis as a risk factor for IUI treatment failure, and while combining IUI with ovarian stimulation (using clomiphene citrate or gonadotropins) improved outcomes, results were not stratified by disease stage